Supports methionine synthase
Methionine synthase can become oxidatively inactive. MTRR participates in the reductive process required to restore the enzyme to a functional state.
The MTRR gene encodes methionine synthase reductase, an enzyme that helps restore active methionine synthase so the folate- and vitamin-B12-dependent remethylation of homocysteine can continue.
MTRR is closely connected with MTR, MTHFR and the wider methylation gene network. Its role is more precise than simply “recycling B12,” and an MTRR genetic result should not be treated as a direct measurement of vitamin B12, folate, homocysteine or overall methylation status.
MTRR provides instructions for making methionine synthase reductase. Its key role is to help restore methionine synthase after that enzyme becomes inactive during normal catalytic cycling.
Methionine synthase can become oxidatively inactive. MTRR participates in the reductive process required to restore the enzyme to a functional state.
Methionine synthase depends on a cobalamin, or vitamin B12, cofactor. MTRR therefore has an important indirect relationship with B12-dependent methionine synthase activity.
By helping maintain functional methionine synthase, MTRR supports the pathway that converts homocysteine back to methionine.
Quick answer: MTRR does not simply “recycle vitamin B12.” It helps reactivate vitamin-B12-dependent methionine synthase, allowing that enzyme to continue transferring a methyl group during the conversion of homocysteine to methionine.
MTR encodes methionine synthase. That enzyme uses methylcobalamin as an intermediate carrier while transferring a methyl group from 5-methyltetrahydrofolate to homocysteine.
During normal enzyme activity, the cobalamin cofactor can become oxidized, leaving methionine synthase inactive. MTRR helps support the reductive reactivation process required to restore functional methionine synthase.
This MTR-MTRR partnership is why both genes commonly appear together in methylation and one-carbon metabolism reports.
MTRR makes more sense when it is viewed as one part of the folate/B12-dependent remethylation pathway rather than as a stand-alone “methylation gene.”
That phrase is often used as shorthand, but it can be misleading. MTRR's better-defined role is helping reactivate methionine synthase, whose catalytic process depends on a cobalamin cofactor.
Methionine synthase uses a vitamin-B12-derived cobalamin cofactor as an intermediate methyl carrier during homocysteine remethylation.
Oxidation of the cobalamin cofactor can temporarily inactivate methionine synthase during normal enzyme cycling.
MTRR participates in the reductive reactivation system that allows methionine synthase to return to its functional state.
MTRR A66G, identified as rs1801394, is one of the most commonly researched MTRR polymorphisms. It is frequently included in studies of folate, vitamin B12 and one-carbon metabolism.
Research has examined possible relationships between this variant and different biochemical or health outcomes. Results are not consistent enough to use an A66G genotype alone as a direct prediction of homocysteine, folate or vitamin B12 status.
rs1801394 identifies a genetic difference in MTRR. A genotype is generally stable and is not a real-time biochemical measurement.
Studies have investigated A66G in many populations and clinical contexts, but an association in one population should not be treated as a universal individual prediction.
MTRR findings are more meaningful when considered alongside MTR, folate-related genes, other metabolic factors and appropriate clinical information.
An MTRR result can identify inherited variation when that marker is included in the test. It cannot substitute for current laboratory measurements.
Bottom line: MTRR genetics can add pathway context, but genotype and current nutrient status are different questions. If B12, folate or homocysteine is clinically important, appropriate laboratory assessment provides different information from a DNA result.
Homocysteine remethylation depends on several connected nutrients, enzymes and pathways. Looking at MTRR alone can make the biology appear much simpler than it actually is.
MTRR is part of a connected one-carbon metabolism network. Reviewing related genes can provide better pathway context than focusing on one polymorphism alone.
Encodes methionine synthase, the B12-dependent enzyme that MTRR helps reactivate.
Participates in folate metabolism and supports production of 5-methyltetrahydrofolate used by methionine synthase.
Provides an alternative homocysteine-remethylation route using betaine rather than the folate/B12-dependent pathway.
Uses SAM as a methyl-group donor in catechol metabolism and provides another view of how methyl groups are used downstream.
If MTRR is one reason you are exploring genetic testing, confirm the exact genes and variants included rather than assuming all methylation tests provide the same coverage.
Check whether the report includes rs1801394 or another MTRR marker and understand exactly what the provider reports.
A useful report should provide context for related genes and pathways rather than assigning a complete interpretation to one polymorphism.
Review the sample methylation report before ordering so you can see how variants, pathways and limitations are explained.
MTRR biology does not change by state, so geographic relevance should focus on the real testing experience: current availability, sample collection, shipping, return instructions and report access.
Before ordering, review U.S. shipping information, testing locations and how the testing process works.
Confirm that the test can currently be ordered and shipped to your location before purchasing.
Understand the required sample, preparation steps and return workflow before starting.
A DNA genotype is different from laboratory measurements of vitamin B12, folate, methylmalonic acid or homocysteine.
MTRR interpretation should distinguish established enzyme biology from association studies involving common polymorphisms.
Clear answers about MTRR, methionine synthase, vitamin B12, homocysteine, A66G and methylation-related genetic testing.
MTRR stands for methionine synthase reductase. The MTRR gene provides instructions for making an enzyme that helps restore functional methionine synthase.
MTRR helps reactivate methionine synthase after oxidative inactivation. Methionine synthase participates in the folate/B12-dependent remethylation of homocysteine to methionine.
That phrase is an oversimplification. MTRR more specifically supports reductive reactivation of methionine synthase, whose catalytic process depends on a cobalamin cofactor.
MTRR A66G is a commonly studied genetic polymorphism identified as rs1801394. Research has examined it in relation to one-carbon metabolism and many health outcomes, but it should not be interpreted as a stand-alone diagnosis or biochemical test.
No. A genetic result does not directly measure current vitamin B12 concentration or functional vitamin B12 status. Those questions require appropriate clinical assessment.
No. Your current homocysteine level is a biochemical measurement and cannot be determined directly from an MTRR genotype.
MTR encodes methionine synthase, which carries out the remethylation reaction. MTRR encodes methionine synthase reductase, which helps restore methionine synthase after it becomes inactive.
They participate in connected one-carbon metabolism pathways, so broader pathway context can be more informative than focusing on either gene alone. Their functions are different and each result still has interpretation limits.
No. An MTRR result alone should not determine vitamin B12, folate or other supplement choices or doses. Those decisions require broader health and clinical context.
Scientific context reviewed August 20, 2026. Gene interpretation and testing specifications should be rechecked as scientific evidence and products evolve.
MTRR is closely connected with methionine synthase, folate, vitamin B12 and homocysteine remethylation, but one genetic variant cannot describe your entire methylation pathway or current nutrient status.
Understand the pathway first, then compare the testing experience.